With our innovative platform technology, we can develop therapeutic vaccines for cancer and therapeutic/preventive vaccines for infectious diseases. We are very open to and hope to collaborate with organizations in areas such as out-licensing, asset acquisitions, strategic partnerships, and joint clinical trial development to expedite the advancement of our novel medications towards clinical trials and eventual commercialization.